Tag: Takeda
-
Takeda Wins FDA Approval for First-in-Class Mimrylo in Polycythemia Vera
The FDA approved Mimrylo (rusfertide), the first hepcidin mimetic for polycythemia vera, introducing iron restriction as a new strategy to control excessive red blood cell production.